Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 1

2475 - Qualitative study of patients’ experiences of living with and beyond a soft tissue sarcoma diagnosis: the impact of sarcoma specialist services

Date

28 Sep 2019

Session

Poster Display session 1

Topics

Tumour Site

Soft Tissue Sarcomas

Presenters

Ana Martins

Citation

Annals of Oncology (2019) 30 (suppl_5): v683-v709. 10.1093/annonc/mdz283

Authors

A. Martins1, L. Storey2, M. Wells3, L.A. Fern4, C. Gerrand5, L. Bennister6, J. Woodford5, M. Onasanya6, R. Windsor7, J. Whelan8, R.M. Taylor4

Author affiliations

  • 1 Cancer Clinical Trials Unit, University College London Hospital UCLH NHS Foundation Trust, NW1 2PG - London/GB
  • 2 School Of Psychology, Queens University Belfast, BT7 1NN - Belfast/GB
  • 3 Nursing Directorate, Imperial College Healthcare NHS Trust, W6 8RF - London/GB
  • 4 Cancer Division, University College London Hospital UCLH NHS Foundation Trust, NW1 2PG - London/GB
  • 5 Sarcoma Unit, The Royal National Orthopaedic Hospital NHS Trust, HA7 4LP - London/GB
  • 6 Patient Representative, Patient Representative, NW1 2 PG - London/GB
  • 7 Paediatric & Adolescent Division, University College London Hospital UCLH NHS Foundation Trust, NW1 2PG - London/GB
  • 8 Oncology, University College London Hospital UCLH NHS Foundation Trust, NW1 2PG - London/GB

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 2475

Background

Treatment of sarcoma often involves long-term hospitalisation, extensive surgery, loss of mobility and complex rehabilitation programmes. Subsequently, poorer patient-reported outcomes are recorded in comparison to patients with other cancer types. A national patient experience survey shows that enhanced levels of reassurance are obtained by access to trusted quality information about sarcoma. Research also shows that patients are more likely to understand their treatment plan, access services, and cope with their illness if they have professionals supporting care coordination. We aim to explore the role of professional’s expertise, practical and emotional support on patients’ experiences.

Methods

Participants across the UK were recruited by healthcare teams or through charities to share their experience of living with and beyond a sarcoma diagnosis. Patients took part in a semi-structured interview or focus group. These were analysed using Framework analysis.

Results

A total of 68 patients with soft tissue sarcoma (STS) participated (59% female; aged 23-82 years; 56% extremity STS; 62% diagnosed within 4 years; 25% with metastatic recurrence). Access to specialist clinical teams had a considerable role in patient’s experience; this restored patient’s trust in the healthcare profession, especially if their route to diagnosis had been long and complex. They shared receiving trusted quality information from specialists. The clinical nurse specialist (CNS) was described as both an expert and approachable professional who gave them practical and emotional support. It was in the absence of clear communication, coordination or when local rehabilitation services lacked the expertise to support patients that worse experiences were reported.

Conclusions

This study showed that having access to professionals with sarcoma expertise, quality trusted information, support from a CNS and access to services in specialist hospitals has an impact on patients’ physical and emotional wellbeing. In contrast, the lack of access to teams with sarcoma expertise/knowledge had a negative impact on patient’s experience. STS is a rare type of cancer and patients benefit from access to specialist services.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

UCLH.

Funding

Sarcoma UK. Phase I Stage 1 received additional support from Bone Cancer Research Trust.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.